[Peri-interventional management of acute endovascular stroke treatment]

Nervenarzt. 2015 Oct;86(10):1217-25. doi: 10.1007/s00115-015-4269-x.
[Article in German]

Abstract

Due to the ground breaking consistent evidence that supports the effect of endovascular stroke treatment (EST), many acute care hospitals and stroke centers will have to be prepared to provide this treatment in an optimal way within the coming years. In addition to the intervention itself, patient preparation, stabilization and monitoring during the treatment as well as the aftercare represent significant challenges and have mostly not yet been sufficiently investigated. Under these aspects, the questions of optimal sedation and airway management have received the highest attention. Based on retrospective study results it already seems to be justified, respecting certain criteria, to prefer EST with the patient under conscious sedation (CS) in comparison to general anesthesia (GA) and to only switch to GA in cases of emergency until this question has been clarified by prospective studies. This and other aspects of peri-interventional management, such as logistics, monitoring, blood pressure, ventilation settings, postprocedural steps of intensive or stroke unit care and imaging follow-up are summarized in this overview. The clinical and radiological selection of patients and thus the decision for intervention or technical aspects of the intervention itself will not be part of this article.

Keywords: Airway management; Conscious sedation; Endovascular stroke treatment; General anesthesia; Peri-interventional management.

Publication types

  • English Abstract

MeSH terms

  • Airway Management / methods*
  • Conscious Sedation / methods*
  • Endovascular Procedures / methods*
  • Evidence-Based Medicine
  • Fibrinolytic Agents / administration & dosage
  • Humans
  • Monitoring, Intraoperative / methods*
  • Perioperative Care / methods*
  • Stroke / diagnosis
  • Stroke / therapy*
  • Tissue Plasminogen Activator / administration & dosage
  • Treatment Outcome

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator